A Phase II Study of Abraxane Gemcitabine Combination in Patients With Metastatic Breast Cancer
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and toxicity of Abraxane combined with
Gemcitabine in the patients with metastatic breast cancer.